← Back to Search

Behavioral Intervention

Breathing Exercises + Meditation for Long Covid

Q: Who is qualified to participate in this scientific endeavor?

<p>This study seeks 68 individuals with <a href="https://www.withpower.com/clinical-trials/covid">Covid</a>-19 ranging from 18 to 70 years of age, who must meet the following requirements: laboratory confirmation of their infection via PCR, willingness to attend an online Breathing and Wellness webinar, a Long Covid diagnosis by a physician, fluency in English language comprehension, and residency within the United States.</p>

N/A

Waitlist Available

Led By Balachundar Subramaniam, MD, MPH

Research Sponsored by Beth Israel Deaconess Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up for phase 1 analysis: baseline to 3 weeks. for phase 2 analysis: baseline to 6 weeks.

Awards & highlights

Study Summary

This trial will test if breathing exercises and meditation can help ease symptoms in people who have had Covid-19 and are still experiencing health problems.

Who is the study for?

This trial is for adults aged 18-70 in the U.S. who have had a lab-confirmed case of COVID-19 and are diagnosed with Long Covid. Participants should understand English and be interested in an online Breathing and Wellness webinar. Those with severe depression, schizophrenia, or bipolar disorder that could limit participation are excluded.Check my eligibility

What is being tested?

The study tests if a digitally delivered breathing practice and guided meditation can help relieve physical and mental symptoms associated with Long Covid when compared to routine daily activities.See study design

What are the potential side effects?

Since this trial involves non-invasive practices like breathing exercises and meditation, side effects may include discomfort or emotional distress but generally are minimal compared to medical or drug interventions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ for phase 1 analysis: baseline to 3 weeks. for phase 2 analysis: baseline to 6 weeks.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~for phase 1 analysis: baseline to 3 weeks. for phase 2 analysis: baseline to 6 weeks.

This trial's timeline: 3 weeks for screening, Varies for treatment, and for phase 1 analysis: baseline to 3 weeks. for phase 2 analysis: baseline to 6 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Compliance

Secondary outcome measures

Multidimensional Dyspnea Profile (MDP)

Perceived Stress Scale (PSS)

Profile of Mood States (POMS)

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Webinar-Based InterventionExperimental Treatment1 Intervention

Breathing and Wellness Webinar: two yogic breathing practices (Simha Kriya and Naddi Shuddi) and a guided meditation (Isha Kriya).

Group II: ControlPlacebo Group1 Intervention

This group will be asked to wait for 3 weeks before being introduced to the Breathing and Wellness Webinar intervention which includes two yogic breathing practices (Simha Kriya and Naddi Shuddi) and a guided meditation (Isha Kriya).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor

836 Previous Clinical Trials

13,010,147 Total Patients Enrolled

5 Trials studying COVID-19

18,632 Patients Enrolled for COVID-19

Balachundar Subramaniam, MD, MPHPrincipal InvestigatorBeth Israel Deaconess Medical Center

3 Previous Clinical Trials

280 Total Patients Enrolled

Media Library

Yogic Breathing and Guided Meditation (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05139979 — N/A

COVID-19 Research Study Groups: Control, Webinar-Based Intervention

COVID-19 Clinical Trial 2023: Yogic Breathing and Guided Meditation Highlights & Side Effects. Trial Name: NCT05139979 — N/A

Yogic Breathing and Guided Meditation (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05139979 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants being welcomed to participate in this clinical trial currently?

"The trial in question, which was first posted on September 15th 2021 and last updated October 6th 2022, is not presently recruiting. Nonetheless, there are 1,311 other clinical trials that require participants at this time."

Answered by AI

Does this research encompass those aged 65 and above?

"This medical trial is seeking participants aged 18 or older and under 70."

Answered by AI

Who is qualified to participate in this scientific endeavor?

"This study seeks 68 individuals with Covid-19 ranging from 18 to 70 years of age, who must meet the following requirements: laboratory confirmation of their infection via PCR, willingness to attend an online Breathing and Wellness webinar, a Long Covid diagnosis by a physician, fluency in English language comprehension, and residency within the United States."

Answered by AI